REG - Burberry Group PLC - Director/PDMR Shareholding

BurberryAnnouncement

11/02/2021 16:40

RNS Number : 8608O
  
Burberry Group PLC
  
11 February 2021
  
 

Burberry Group plc (the "Company") - Director/PDMR Shareholding
 
The Company announces that it received notification on 11 February 2021 that Debra Lee, a Non-Executive Director, purchased 520 Ordinary Shares of 0.05 pence each in the Company ("Shares") on 11 February 2021 at a price of 1725.00 pence per Share.
 
11 February 2021
 
 
The following disclosures are made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
Notification of dealing form



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Debra Lee




2


Reason for the notification




a)


Position/status


Non-Executive Director




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Burberry Group plc




b)


LEI


213800PE1KEFCNFR1R50




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument
Identification code


Ordinary shares of 0.05 pence each
 
 
GB0031743007




b)


Nature of the transaction


Purchase of ordinary shares




c)


Price(s) and volume(s)


 



Price(s)


Volume(s)




£17.2500
 


520



 
 




d)


Aggregated information
 
- Aggregated volume
 
- Price
 


 



Aggregate Price


Aggregate Volume


Aggregate
Total




£17.2500
 


520


£8,970.00








e)


Date of the transaction


2021-02-11
 




f)


Place of the transaction


XLON





















 
 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHFLFVRFEILLIL